BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.



Figure 7. Percentage changes in tumour perfusion with combretastatin (CA4P) at (A) 30 min and (B) 24 h after infusion. A threshold response is clearly seen. Kindly reproduced with permission from: Anderson H, Yap J, Miller M, Robbins A, Jones T, Price P. Assessment of pharmacodynamic vascular response in a Phase I trial of combretastatin A4 phosphate. J Clin Oncol 2003;21:2823–30.





Right arrow Return to article

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS